vimarsana.com

Latest Breaking News On - Emmes the company - Page 1 : vimarsana.com

Behrman Capital Sells Portfolio Company Emmes to Affiliates of New Mountain Capital

/PRNewswire/ Behrman Capital, a private equity investment firm based in New York, today announced the sale of its portfolio company Emmes (the "Company") to.

New yorkUnited statesSal guccioneChristine dingivanDarrylg behrmanRoss lovern teagan chapmanRothschild coHuman servicesDepartment of defenseNational institutes of healthBiomedical advanced researchDrug administrationDevelopment authorityEmmes the companyDepartment of healthGoodwin procter

Emmes Acquires Institut Dr Schauerte, Entering Real World Evidence Market

/PRNewswire/ Emmes (the "Company"), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and.

New yorkUnited statesUnited kingdomCzech republicChristine dingivanWulfram schauerteEmmes europeRoss lovern daniel hoadleyDarrylg behrmanEmmes the companyClinical research organizationBehrman capitalUnited kingdom based orphan reachManaging partnerOrphan reachChief executive officer

Emmes Acquires Institut Dr Schauerte, Entering Real World Evidence Market

/PRNewswire/ Emmes (the "Company"), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and.

New yorkUnited statesUnited kingdomCzech republicChristine dingivanWulfram schauerteEmmes europeRoss lovern daniel hoadleyDarrylg behrmanEmmes the companyClinical research organizationBehrman capitalUnited kingdom based orphan reachManaging partnerOrphan reachChief executive officer

Emmes Acquires UK-Based Orphan Reach

/PRNewswire/ Emmes (the "Company"), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and.

New yorkUnited statesUnited kingdomCounty dun laoghaire rathdownSan franciscoChristine dingivanRhonda henryRoss lovern daniel hoadleyNeoxs ro neoxDarrylg behrmanEmmes biopharmaThomas ogorkaEmmes the companyCompany biopharmaClinical research organizationBehrman capital

vimarsana © 2020. All Rights Reserved.